News

The companies announced a long-term collaboration to make obesity treatments more affordable, they said on Tuesday.
Him & Hers Health and Novo Nordisk are collaborating to offer weight-loss treatment, including access to Wegovy along with ...
Hims and Hers Health Inc. soared in pre-market trading after Novo Nordisk A/S said it would sell its popular weight-loss drug ...
Novo Nordisk has launched its hugely popular weight-loss drug Wegovy in Thailand, an executive of the Danish drugmaker's ...
Novo Nordisk A/S faces challenges in the obesity market, but new trials and innovations offer hope. Read more on NVO stock ...
Shares of online health platform Hims & Hers Health soared Tuesday after the company announced a partnership with Novo ...
Telehealth providers will soon offer more affordable access to weight loss drug Wegovy, according to manufacturer Novo ...
Hims & Hers on Tuesday announced a collaboration with drugmaker Novo Nordisk to bundle Wegovy and a Hims & Hers membership on ...
Since launching its wildly popular weight-loss drug Wegovy in 2021, Novo Nordisk has raised its annual sales guidance several ...
Novo Nordisk appears to be letting compounded GLP-1 bygones be bygones—at least, in one respect. | Novo Nordisk appears to be ...
A batch of the drug is under a limited voluntary recall after a shipping error exposed certain doses to improper temperatures.